Skip to main content
logo
Lakefront Biotherapeutics NV (AMS:LKFT)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
23.96
+0.08 (0.34%)
Sep 16, 2026, 5:35 PM CET

AMS:LKFT Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,5521,8451,7482,4382,7223,227
Market Cap Growth
-12.91%5.58%-28.31%-10.46%-15.63%-38.71%
Enterprise Value
-681-1,197-1,580-1,360-1,617-1,621
Last Close Price
23.8828.0026.5236.9941.3549.22

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.655.7523.5911.51--
Forward PE
-128.80128.80128.80128.80128.80
PS Ratio
1.571.666.3410.1711.2813.77
PB Ratio
0.480.570.600.871.081.22
P/TBV Ratio
0.620.570.660.941.171.24
PEG Ratio
-2.592.592.592.592.59

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.010.01
Debt / EBITDA Ratio
0.010.01----
Net Debt / Equity Ratio
-0.68-0.92-1.07-1.31-1.61-1.77
Net Debt / EBITDA Ratio
-3.92-5.2620.2688.6162.1828.64
Net Debt / FCF Ratio
9.6511.039.228.657.718.38
Asset Turnover
0.280.300.070.050.050.04
Inventory Turnover
15.1613.285.923.807.3430.64
Quick Ratio
32.6519.969.578.767.988.53
Current Ratio
32.8420.159.979.028.118.58
Return on Equity (ROE)
20.12%10.42%-0.04%-0.15%-2.76%-4.55%
Return on Assets (ROA)
9.93%8.87%-2.75%-1.17%-1.65%-1.97%
Return on Invested Capital (ROIC)
87.08%2988.46%----
Return on Capital Employed (ROCE)
17.40%16.50%-4.90%-2.20%-3.10%-3.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
38.45%17.39%4.24%8.69%-8.01%-3.20%
FCF Yield
-14.92%-14.70%-19.27%-17.42%-19.39%-17.29%
Buyback Yield / Dilution
-0.05%0.06%-0.01%-0.36%-0.30%-0.65%